Berino, Ma Corazon E.
HRN: 23-82-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/05/2023
MUPIROCIN 2%, 15G (TUBE)
10/05/2023
10/08/2023
TOPICAL
2% Small Amount
BID
Blistered Lesion
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes